Announcements Trials
Browse Landscape

Phase

Phase NA 4Phase 3 4Phase 4 2Phase 2/3 2Phase 2 1Phase 1/2 1Phase 1 1

Status

Terminated 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Tumor-Agnostic 1Thoracic 1

Conditions

Pain, Postoperative 3Neoplasms 2Warts 1Urinary Bladder Neoplasms 1Spinal Cord Neoplasms 1Shock, Septic 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Pleural Effusion 1Papillomavirus Infections 1Liver Neoplasms 1Depression 1Carcinoma, Hepatocellular 1

Interventions

Trimethoprim, Sulfamethoxazole Drug Combination 4gamma-Globulins 3Standard of Care 3Oxaliplatin 3Melatonin 3Gemcitabine 3Fluorouracil 3Drug Therapy 3Ciprofloxacin 3Capecitabine 3pertuzumab 2entrectinib 2cobimetinib 2capmatinib 2atezolizumab 2alectinib 2Water 2Vemurafenib 2Trastuzumab 2Sirolimus 2Saline Solution 2Pemetrexed 2Methylphenidate 2Lidocaine 2Leucovorin 2Immunoglobulins, Intravenous 2Docetaxel 2Dexmedetomidine 2Cisplatin 2Carboplatin 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2/3 × Neoplasms × Saline Solution × Clear all
NCT01580618 2026-04-14

Tenecteplase (TNK) for Loculated Pleural Effusions in Patients With Malignancy

Kaiser Permanente

Phase 2/3 Terminated
20 enrolled 11 charts
Thoracic

Neoplasms, Pleural Effusion

NCT07279792 2025-12-29

Implications of Post-Operative Irrigation Fluid's Osmolarity on the Recurrence of Non-Muscle Invasive Bladder Cancer Following Transurethral Resection

Ain Shams University

Phase 2/3 Completed
150 enrolled
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡